Dual antiplatelets reduce microembolic signals in patients with transient ischemic attack and minor stroke: Subgroup analysis of CLAIR study

International Journal of Stroke

Volumn 9, Issue A100, 2014, Pages 127-132

  Lau, Alexander Y ^a   Zhao, Yudong ^b   Chen, Christopher ^c   Leung, Thomas W ^a   Fu, Jianhui ^d   Huang, Yining ^e   Suwanwela, Nijasri C ^f   Han, Zhao ^g   Tan, Kay Sin ^h   Ratanakorn, Disya ⁱ   Markus, Hugh S ^j   Wong, Ka Sing ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SINGAPORE CLINICAL RESEARCH INSTITUTE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d FUDAN UNIVERSITY   (China)

^e PEKING UNIVERSITY FIRST HOSPITAL   (China)

^f KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^g THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^h UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

ⁱ MAHIDOL UNIVERSITY   (Thailand)

^j ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

more..

Author keywords

Combination antiplatelets; Stroke; Transcranial Doppler; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; MIDDLE AGED; MINOR ISCHEMIC STROKE; MONOTHERAPY; MUCOSAL BLEEDING; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; RISK REDUCTION; SCORING SYSTEM; SECONDARY PREVENTION; SHORT COURSE THERAPY; SIGNAL DETECTION; SUBCUTANEOUS HEMORRHAGE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; AGED; ANALOGS AND DERIVATIVES; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPLICATION; DRUG COMBINATION; ECHOGRAPHY; INTRACRANIAL EMBOLISM; MOLECULAR GENETICS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TIME;

ADULT; AGED; ASPIRIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTRACRANIAL EMBOLISM; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PLATELET AGGREGATION INHIBITORS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; TICLOPIDINE; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84911932496     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12003     Document Type: Article

References (22)

1. Rothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 2006; 5:323-331.
2. Coull AJ, Lovett JK, Rothwell PM. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004; 328:326.
3. Wong LK. Global burden of intracranial atherosclerosis. Int J Stroke 2006; 1:158-159.
4. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008; 39:2396-2399.
5. Ovbiagele B, Cruz-Flores S, Lynn MJ, Chimowitz MI. Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol 2008; 65:733-737.
6. Adams HP Jr, del Zoppo G, Alberts MJ etal. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38:1655-1711.
7. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25:457-507.
8. Easton JD. Antithrombotic management for transient ischemic attack and ischemic stroke (other than atrial fibrillation). Curr Atheroscler Rep 2011; 13:314-320.
9. Usman MH, Notaro LA, Nagarakanti R etal. Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble? Am J Cardiol 2009; 103:1107-1112.
10. Furie KL, Kasner SE, Adams RJ etal. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2011; 42:227-276.
11. Rothwell PM, Algra A, Amarenco P. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet 2011; 377:1681-1692.
12. Caplan LR, Wong KS, Gao S, Hennerici MG. Is hypoperfusion an important cause of strokes? If so, how? Cerebrovasc Dis 2006; 21:145-153.
13. Forster A, Szabo K, Hennerici MG. Pathophysiological concepts of stroke in hemodynamic risk zones - do hypoperfusion and embolism interact? Nat Clin Pract Neurol 2008; 4:216-225.
14. King A, Markus HS. Doppler embolic signals in cerebrovascular disease and prediction of stroke risk: a systematic review and meta-analysis. Stroke 2009; 40:3711-3717.
15. Gao S, Wong KS, Hansberg T, Lam WW, Droste DW, Ringelstein EB. Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke 2004; 35:2832-2836.
16. Markus HS, Droste DW, Kaps M etal. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005; 111:2233-2240.
17. Wong KS, Chen C, Fu J etal. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010; 9:489-497.
18. Coutts SB, Modi J, Patel SK, Demchuk AM, Goyal M, Hill MD. CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. Stroke 2012; 43:1013-1017.
19. Poisson SN, Nguyen-Huynh MN, Johnston SC, Furie KL, Lev MH, Smith WS. Intracranial large vessel occlusion as a predictor of decline in functional status after transient ischemic attack. Stroke 2011; 42:44-47.
20. Johnston SC, Rothwell PM, Nguyen-Huynh MN etal. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369:283-292.
21. Wang Y, Johnston SC. Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. Am Heart J 2010; 160:380-386. e1.
22. Itabashi R, Mori E, Furui E, Sato S, Yazawa Y, Fujiwara S. Combination oral antiplatelet therapy may increase the risk of hemorrhagic complications in patients with acute ischemic stroke caused by large artery disease. Thromb Res 2011; 128:541-546.